Additionally, about 11% to 19% of patients diagnosed with TNBC have either germline or somatic BRCA1 mutations, highlighting the genetic link between BRCA1 alterations and this aggressive breast cancer subtype [34,35]. This evidence concerns the gene BRCA1 and breast cancer.